IntelGenx, ATAI partner on film-based psychedelics
The companies will join forces to use IntelGenx’s polymeric film technologies for development of pharmaceutical-grade psychedelic drug treatments.
Archives for September 3, 2020
Elligo: increasing diversity can elevate trials
A company leader outlines the importance of increasing diversity in clinical trial patient populations, and how researchers can improve their results.
COVID-19 treatment study predicts adverse drug events
Innovative research by Tabula Rasa Healthcare uses simulation technology to analyze potential adverse drug events of potential therapies for the virus.